APA (7th ed.) Citation

JJ, K., C, K., P, G., D, K., L, G., M, E., . . . H, G. (2025). Event-free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa-2b or hydroxyurea/best available therapy (PROUD-PV/CONTINUATION-PV). HemaSphere, 9(5), e70137. https://doi.org/10.1002/hem3.70137

Chicago Style (17th ed.) Citation

JJ, Kiladjian, et al. "Event-free Survival in Early Polycythemia Vera Patients Correlates with Molecular Response to Ropeginterferon Alfa-2b or Hydroxyurea/best Available Therapy (PROUD-PV/CONTINUATION-PV)." HemaSphere 9, no. 5 (2025): e70137. https://doi.org/10.1002/hem3.70137.

MLA (9th ed.) Citation

JJ, Kiladjian, et al. "Event-free Survival in Early Polycythemia Vera Patients Correlates with Molecular Response to Ropeginterferon Alfa-2b or Hydroxyurea/best Available Therapy (PROUD-PV/CONTINUATION-PV)." HemaSphere, vol. 9, no. 5, 2025, p. e70137, https://doi.org/10.1002/hem3.70137.